Evidence map›Paper›PMID 24322524›Full record

ReviewNutrients2013

Cancer preventive efficacy of marine carotenoid fucoxanthin: cell cycle arrest and apoptosis.

Thamaraiselvan Rengarajan, Permaiyan Rajendran, Natarajan Nandakumar, Maruthaiveeran Periyasamy Balasubramanian, Ikuo Nishigaki

Abstract readReview
In one paragraph

Review in Nutrients, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Fucoxanthin fromMarine drugs · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Michael Acceptors as Anti-Cancer Compounds: Coincidence or Causality?International journal of molecular sciences · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Rapid Purification of Fucoxanthin fromMolecules (Basel, Switzerland) · 2022
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Thamaraiselvan RengarajanNPO-International Laboratory of Biochemistry, 1-166, Uchide, Nakagawa-ku, Nagoya 454-0926, Japan. nishigaki@se.starcat.ne.jp.
Permaiyan Rajendran
Natarajan Nandakumar
Maruthaiveeran Periyasamy Balasubramanian
Ikuo Nishigaki

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epidemiological investigations have shown that overcoming the risk of cancer is related to the consumption of green vegetables and fruits. Many compounds from different origins, such as terrestrial plants and marine and microbial sources, have been reported to have therapeutic effects of which marine sources are the most important because the diversity of marine life is more varied than other sources. Fucoxanthin is one important compound with a marine origin and belongs to the group of carotenoids; it can be found in marine brown seaweeds, macroalgae, and diatoms, all of which have remarkable biological properties. Numerous studies have shown that fucoxanthin has considerable medicinal potential and promising applications in human health. In this review, we summarize the anticancer effects of fucoxanthin through several different mechanisms including anti-proliferation, induction of apoptosis, cell cycle arrest and anti-angiogenesis, and its possible role in the treatment of cancer.

Indexed as

Angiogenesis InhibitorsAnticarcinogenic AgentsApoptosisCell Cycle CheckpointsHumansNeoplasmsSeaweedXanthophyllsAngiogenesis InhibitorsAnticarcinogenic AgentsfucoxanthinXanthophylls

Identifiers

PMID24322524
PMCPMC3875925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.